Arkolith/Insider Trading/BRTX/Form 4

Silva Francisco

VP of Research and Development, Director, 10% OwnerBioRestorative Therapies, Inc. (BRTX) · full profile →Form 4 · filed Mar 22, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 20, 2023Tax withholding(F)7K$2.92$20K159K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001021771-23-000028) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML